Silicon Valley Bank Results Presentation Deck
Persistent market volatility and deal closing delays reduced investment banking transactions
Expect $460-500M FY'22 SVB Securities revenue
المسلم
www.w
Life Sciences/Healthcare
Tools &
Diagnostics
Institutional
Equities
Alternative
Equities
svb>
Convertible
Securities
Digital Health &
Health Tech
Medical
Devices
Equity
MEDACorp Research
svb>
Securities
Private
Placements
Biopharma
Healthcare
Services
SPACS
Equity
Capital
Markets
M&A
Advisory
Leveraged
Finance
Structured
Finance
Education
Technology
Technology (launched September 2021)
Consumer
Software,
Internet &
Info Services
Enterprise
Software
Fintech
טטט
Industrial
Technology
Digital Infra &
Tech Services
Q3'22 activity
SVB Securities revenue declined $50M QOQ as persistent market volatility and
deal closing delays reduced advisory and capital markets transactions deal pipeline
remains healthy
• Compensation from prior year hiring drove SVB Securities expenses higher than revenue
SVB
Securities
revenue¹
$M
107
17
25
26
39
Q3'21
$142M
145
21
17
51
56
Q4'21
$184M
118
25
7
54
32
Q1'22
$134M
Q4'22 considerations
Expect Q4 SVB Securities revenue -$95-125M:
149
24
15
69
1. Non-GAAP financial measure. See "Use of non-GAAP Financial Measures" in our Q3 2022 Earnings Release and our non-GAAP reconciliations
at the end of this presentation.
2. Included in investment banking revenue.
3. Included in FY'22 outlook for SVB Securities revenue of $460-500M.
41
Q2'22
$141M
99
24
11
40
24
Q3'22
$131M
Strengthening collaboration
Between Silicon Valley Bank and SVB Securities
-
Commissions
Private placements and other²
M&A advisory²
Underwriting fees²
Prolonged market volatility
Pressures later-stage/public valuations, delaying near-term ECM activity
SVB Securities
expenses
New hires and expertise
Hiring and investment over the past year to grow Technology, Healthcare Services
and Health Tech investment banking help diversify business
Combined new initiatives expected to contribute ~$130-180M of revenues in 2022³
Continue to fill out team and capabilities
Q3 2022 FINANCIAL HIGHLIGHTS 31View entire presentation